How have ARSUF shares performed in 2023?

Fagron's stock was trading at $13.50 at the beginning of the year. Since then, ARSUF shares have increased by 28.1% and is now trading at $17.2877. View the best growth stocks for 2023 here .

Are investors shorting Fagron?

Fagron saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 16,100 shares, an increase of 7.3% from the October 15th total of 15,000 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 161.0 days. View Fagron's Short Interest .

Is Fagron a good dividend stock?

Fagron (OTCMKTS:ARSUF) pays an annual dividend of $0.54 per share and currently has a dividend yield of 1.72%.

How do I buy shares of Fagron?

Shares of ARSUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Fagron Stock Price, News & Analysis (OTCMKTS:ARSUF)

$17.29

0.00 (0.00%)

(As of 11/29/2023 ET)

Compare

Today's Range: $17.29
▼
$17.29
50-Day Range: $17.29
▼
$17.88
52-Week Range: $16.15
▼
$18.75

Volume: N/A
Average Volume: 8,850 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: 3.12%
Price Target: N/A

Stock Analysis Chart Short Interest

About Fagron Stock (OTCMKTS:ARSUF)

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

ARSUF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ARSUF Stock News Headlines

October 13, 2022 | finance.yahoo.com

Fagron delivers topline growth of 21.5% to €173 million

September 27, 2022 | finance.yahoo.com

Fagron commits to set science-based emission reduction targets

November 30, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

September 8, 2022 | reuters.com

FAGRO.BR - Fagron NV | Stock Price & Latest News | Reuters

September 4, 2022 | yahoo.com

Disclosure of received notification of Kabouter Management LLC

August 8, 2022 | seekingalpha.com

Fagron NV (ARSUF) CEO Rafael Padilla on Q2 2022 Results - Earnings Call Transcript

August 4, 2022 | finance.yahoo.com

Fagron delivers strong topline growth of 18.8% and an increase in REBITDA of 13.1% for the first half of 2022

June 13, 2022 | finance.yahoo.com

Fagron increases share capital through exercise subscription rights

November 30, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

May 9, 2022 | ca.finance.yahoo.com

Fagron shareholders approve all voting items AGM and EGM

April 14, 2022 | uk.finance.yahoo.com

Fagron reports 16% increase in revenue to € 156.4 million

April 8, 2022 | nz.finance.yahoo.com

Fagron publishes agenda 2022 annual general meeting and extraordinary general meeting

March 15, 2022 | msn.com

Fagron expands Wichita facility, creating 150 new jobs

March 15, 2022 | finance.yahoo.com

Fagron to present medium-term strategic objectives at its Capital Markets Day

March 7, 2022 | sg.finance.yahoo.com

Full year ‘21 results Fagron in line with expectations

February 2, 2022 | finance.yahoo.com

Fagron strengthens position in US with acquisition of Letco and divestment of non-core activities

See More Headlines

Receive ARSUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fagron and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:ARSUF
CUSIP: N/A
CIK: N/A
Web: www.fagron.com
Phone: 32.8.001.28.80
Fax: N/A
Employees: 3,035
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Rafael Padilla (Age 45)
CEO & Executive Director
Comp: $712.8k
Ms. Karin de Jong (Age 44)
CFO & Executive Director
Comp: $1.1M
Ms. Vera Bakker (Age 51)
Chief Operating Officer
Comp: $8.22k
Karen Berg
Global Investor Relations Manager
Mr. Johan Verlinden
Head of Legal, Mergers & Acquisitions

Key Competitors

View All Competitors

ARSUF Stock Analysis - Frequently Asked Questions

How have ARSUF shares performed in 2023?: Fagron's stock was trading at $13.50 at the beginning of the year. Since then, ARSUF shares have increased by 28.1% and is now trading at $17.2877.
View the best growth stocks for 2023 here.
Are investors shorting Fagron?: Fagron saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 16,100 shares, an increase of 7.3% from the October 15th total of 15,000 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 161.0 days.
View Fagron's Short Interest.
Is Fagron a good dividend stock?: Fagron (OTCMKTS:ARSUF) pays an annual dividend of $0.54 per share and currently has a dividend yield of 1.72%.
How do I buy shares of Fagron?: Shares of ARSUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:ARSUF) was last updated on 11/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial